1 / 27

Nephrotic Syndrome Case Presentation

Tuesday 4 th January 2011 Dr Matthew Home. Nephrotic Syndrome Case Presentation. Case presentation Definition Causes Guidelines References. contents. Born AGH Term (40 weeks) Apgars 7 1 / 9 5 Well since Immunisations up-to-date Four brothers (8, 11, 16, 17 yrs) all well

jewel
Download Presentation

Nephrotic Syndrome Case Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Tuesday 4th January 2011 Dr Matthew Home Nephrotic SyndromeCase Presentation

  2. Case presentation • Definition • Causes • Guidelines • References contents

  3. Born AGH • Term (40 weeks) • Apgars71/ 95 • Well since • Immunisations up-to-date • Four brothers (8, 11, 16, 17 yrs) all well • No regular medications • NKDA Previous history

  4. S/B GP ~14/09/2010 Facial swelling – particularly periorbitally Loss of Appetite Flu symptoms (Rhinorheoa, Fevers) a few weeks before Arrange bloods and follow-up appointment Presentation

  5. Follow-up appointment not attended S/B GP again on 04/10/2010 • Abdominal pain and distension • Ankle swelling • Continued loss of appetite • “Drinking plenty of fluids” • Increased urine volume • No dysuria, haematuriaor offensive urine • Bowels - trace blood (Recent prolapse) • No rash, fever

  6. Haemoglobin  13.4 g/dL 11.5 - 17.5 White Cell Count  8.8 x109/L 3.7 - 15.5 Platelets  492 x109/L 140 - 450 Sodium 135 mmol/L 132 - 143 Potassium  4.4 mmol/L 3.2 - 5.7 Bicarbonate  24.5 mmol/l 13 - 29 Urea  2 mmol/L 1.8 - 9.6 Creatinine18umol/L 27 - 88 Chloride  106 mmol/L 96 - 114 Calcium  2.07mmol/L 2.14 - 2.62 Total Protein  35 g/l 56 - 77 Albumin  less thn 10 ALT  12 IU/L Nov-39 Alkaline Phosphatase  118 IU/L 110 - 302 Total Bilirubin  6 umol/L 0 - 34 Vitamin D 17nmol/L 60 - 150 Free T4 8.7 pmol/L 7.5 - 21.1 Ferritin 19 ng/mL 14 - 180 TSH  8.58 miu/L 0.34 - 5.6 Bloods / Urine Dip (14/09/2010)

  7. Examination • P 118, BP 109/63, SaO2 99% RA • Chest – Clear • HS - I + II + 0 • ENT - NAD • Abdomen • moderately distended (Ascites) • No palpable L/S/K/K • Peripheral odema +

  8. Haemoglobin  13.7 g/dL 11.5 - 17.5 White Cell Count  7.7 x109/L 3.7 - 15.5 Platelets  437 x109/L 140 - 450 Sodium  136 mmol/L 132 - 143 Potassium  4.1 mmol/L 3.2 - 5.7 Bicarbonate  23.8 mmol/l 13 - 29 Urea  3.2mmol/L 1.8 - 9.6 Creatinine13umol/L 27 - 88 Chloride  105 mmol/L 96 - 114 Calcium  2.21 mmol/L 2.14 - 2.62 Total Protein  47 g/l 56 - 77 Albumin  16 g/L 31 - 48 Corrected Calcium  2.69mmol/L 2.14 - 2.62 Globulin  31 g/L 23 - 41 ALT  18 IU/L 11-39 Alkaline Phosphatase  91 IU/L 110 - 302 Total Bilirubin  8 umol/L 0 - 34 Blood Culture (Aerobic): No growth (5 days) VZV IgG Antibodies  Positive Plasma Glucose  4.8 mmol/L 3.0 - 12.0 Antistreptolysin-O  1 IU/mL 0 - 200 TSH  10.72miu/L 0.34 - 5.6 Free T4  7.5 pmol/L 7.5 - 21.1 Thyroid PeroxidaseLess than 10 Bloods on admission (04/10/2010)

  9. Urine Dip Protein +++

  10. Nephrotic Syndrome Vitamin D Deficiency Diagnosis

  11. Nephroticrange proteinuria (> 1g/m2/day) • Hypoalbuminaemia(<25 g/l) • Oedema Classification • Idiopathic (primary) nephrotic syndrome • Minimal change (80-90%) • Focal segmental glomerulosclerosis (FSGS) (10-20%) • Secondary nephrotic syndrome (HSP, SLE, MPGN) • Congenital nephrotic syndrome Nephrotic Syndrome Definition

  12. Minimal-change disease (MCD) • Also known as lipoid nephrosis or nil disease • It refers to a histopathologic lesion in the glomerulus • Disorder of T cells, which release a cytokine that injures the glomerular epithelial foot processes.

  13. Focal Segmental Glomerulosclerosis • ?viral- or toxin-mediated damage or intrarenal hemodynamic changes such as hyperperfusion and high intraglomerular capillary pressure • Injury to podocytes • shrinkage/collapse of glomerular capillaries • scarring (glomerulosclerosis)

  14. Idiopathic NS • MCNS • FSGS • MPGN • Membranous glomerulonephritis (MGN) • IgA nephropathy • Idiopathic crescenticglomerulonephritis • Genetic nephrotic syndrome/congenital nephrotic syndrome • Finnish-type congenital nephrotic syndrome (NPHS1, nephrin) • Denys-Drash syndrome (WT1) • Frasier syndrome (WT1) • Diffuse mesangial sclerosis (WT1, PLCE1) • Autosomal recessive, familial FSGS (NPHS2, podocin) • Autosomal dominant, familial FSGS (ACTN4, α-actinin-4; TRPC6) • Nail-patella syndrome (LMX1B) • Pierson syndrome (LAMB2) • Schimkeimmuno-osseous dysplasia (SMARCAL1) • Galloway-Mowat syndrome • Oculocerebrorenal (Lowe) syndrome • Secondary nephrotic syndrome • Infections • Congenital syphilis, toxoplasmosis, cytomegalovirus, rubella • Hepatitis B and C • HIV/acquired immunodeficiency syndrome (AIDS) • Malaria • Drugs • Penicillamine • Gold • Nonsteroidal anti-inflammatory drugs (NSAIDs) • Interferon • Mercury • Heroin • Pamidronate • Lithium • Systemic disease • Systemic lupus erythematosus • Malignancy - Lymphoma, leukemia • Vasculitis -Wegener granulomatosis, Churg-Strauss syndrome, polyarteritisnodosa, microscopic polyangiitis, Henoch-Schönleinpurpura (HSP) • Immune-complex–mediated - Poststreptococcalglomerulonephritis Nephrotic Syndrome - Causes

  15. Nephrotic Syndrome - Idiopathic Typical Features Age 1-10 years Normotensive Normal Adrenal Function +/- microscopic haematuria Atypical Features <1yr, >10years Hypertensive Elevated Creatinine Macroscopic Haematuria

  16. Blood: FBC, U+E’s; Creatinine; LFT’s; ASOT; C3/C4; Varicella titres • Urine: Urine culture and Urinary protein/creatinine ratio • BP • Urinalysis including glucose • A urinary sodium concentration can be helpful in those at risk of hypovolaemia. • Varicellastatus should be known in all children commencing steroids. • Hepatitis B status may be appropriate in children at high risk. Nephrotic Syndrome - Investigations

  17. Age < 1 yr Age > 10-12 yrs Persistent hypertension Macroscopic haematuria Low C3/C4 Failure to respond to steroids within 4 weeks Nephrotic Syndrome - Referral

  18. Hypovolaemia • Despite odema may be intra-vascularly depleted • Infection • Loss of complement components • Thrombosis • Loss of proteins and exacerbated by hypovolaemia Nephrotic Syndrome - Complications

  19. Prednisolone +/- Ranitidine • Albumin where indicated + Frusemide mid-infusion • Penicillin prophylaxis • Salt/Fluid Restriction • Vaccination Treatment

  20. Remission – 3+ days of trace / - protein on dipstick testing Up to 60 - 70 % of children may have one or more relapse. Urine check twice weekly initially, then weekly Monitoring

  21. Prednisolone • Albumin • Salt Restriction • Penicillin • Varicella vaccine • Consider between relapses in children who are varicella seronegative. Treatment of Relapsing NS

  22. Referral to / Discussion with Paediatric Nephrology if Frequent relapsers Steroid dependency Steroid toxicity Referral of Relapsing NS

  23. Frequent relapsers are diagnosed if there is: • 2 or more relapses within the first 6 months of presentation • 4 or more relapses within any 12 month period • This becomes steroid dependency if the relapses are occurring during steroid tapering. • Varicella status should be repeated 6 monthly in those who are non-immune. Frequent Relapses

  24. Low Dose Alternate Day Prednisolone Levamisole Cyclophosphamide Cyclosporin Mycophenylate Mofitil (MMF) Treatment of Frequent Relapses

  25. Prednisolone 60mg/m2 • Ranitidine • Penicillin V • DalavitVit D Suppliments • HAS 20% @ 5ml/kg with Frusemide 1mg/kg half way through x3 • Urinalysis with each void • Monitor daily urine output • Daily weights – adjust fluid restriction accordingly • Fluid restrict to 600ml/day • D/W Leeds renal team Our Case - Plan

  26. Review 15/10/10 • Odemasettled • Persistent Proteinuira Pro+++ • Penicillin V stopped • Continue Prednisolone Review 22/10/10 • Odema settled • Persistent Proteinuira Pro+++ • Penicillin V stopped • Continue Prednisolone Review 29/10/10 • Persistent Pro+++ • Prednisolonechanged to 40mg/m2 - 25mg alt days Review 13/11/10 • Persistent Pro+++ • Restart Penicillin V 125mg BD • Referred to Paediatric renal team for ?renal biopsy Case progress

  27. www.gpnotebook.co.uk/ http://emedicine.medscape.com/ http://www.clinicalguidelines.scot.nhs.uk/ www.newcastle-hospitals.org.uk/ References

More Related